These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18772576)

  • 1. [A case of toxic epidermal necrolysis with severe intestinal manifestation].
    Otomi M; Yano M; Aoki H; Takahashi K; Omoya T; Suzuki Y; Nakamoto J; Kataoka K; Yagi Y; Yamamoto Y
    Nihon Shokakibyo Gakkai Zasshi; 2008 Sep; 105(9):1353-61. PubMed ID: 18772576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bucillamine-induced toxic epidermal necrolysis and fixed drug eruption.
    Izumi A; Katsumi S; Kobayashi N; Niizeki H; Asada H; Miyagawa S
    J Dermatol; 2005 May; 32(5):397-401. PubMed ID: 16043905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.
    Tremblay L; Pineton de Chambrun G; De Vroey B; Lavogiez C; Delaporte E; Colombel JF; Cortot A
    J Crohns Colitis; 2011 Oct; 5(5):457-60. PubMed ID: 21939920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fatal case of cutaneous adverse drug-induced toxic epidermal necrolysis associated with severe rhabdomyolysis.
    Noordally SO; Sohawon S; Vanderhulst J; Duttmann R; Corazza F; Devriendt J
    Ann Saudi Med; 2012; 32(3):309-11. PubMed ID: 22588445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fever in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Cases: Laboratory Work-up and Antibiotic Therapy.
    Paulmann M; Mockenhaupt M
    Pediatr Infect Dis J; 2017 May; 36(5):513-515. PubMed ID: 28403057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Fritsch PO; Sidoroff A
    Am J Clin Dermatol; 2000; 1(6):349-60. PubMed ID: 11702611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxic epidermal necrolysis].
    Mao Martín L; Hernández Blanco C; Antolín Arias J; Cabello Carro J
    Med Clin (Barc); 2008 Sep; 131(8):320. PubMed ID: 18803930
    [No Abstract]   [Full Text] [Related]  

  • 12. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature.
    Yildirim Cetin G; Sayar H; Ozkan F; Kurtulus S; Kesici F; Sayarlioglu M
    Lupus; 2013 Jul; 22(8):839-46. PubMed ID: 23761100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical resemblance of widespread bullous fixed drug eruption to Stevens-Johnson syndrome or toxic epidermal necrolysis: report of two cases.
    Lin TK; Hsu MM; Lee JY
    J Formos Med Assoc; 2002 Aug; 101(8):572-6. PubMed ID: 12440088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevens Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: a retrospective study of causative drugs and clinical outcome.
    Sharma VK; Sethuraman G; Minz A
    Indian J Dermatol Venereol Leprol; 2008; 74(3):238-40. PubMed ID: 18583791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic epidermal necrolysis probably due to cosmetic cream: a case report.
    Kokcam I
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Mar; 18(1):39-42. PubMed ID: 19350188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ofloxacin: a probable cause of toxic epidermal necrolysis.
    Melde SL
    Ann Pharmacother; 2001 Nov; 35(11):1388-90. PubMed ID: 11724089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome.
    Petkov T; Pehlivanov G; Grozdev I; Kavaklieva S; Tsankov N
    Eur J Dermatol; 2007; 17(5):422-7. PubMed ID: 17673387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vemurafenib-induced toxic epidermal necrolysis].
    Wantz M; Spanoudi-Kitrimi I; Lasek A; Lebas D; Quinchon JF; Modiano P
    Ann Dermatol Venereol; 2014 Mar; 141(3):215-8. PubMed ID: 24635957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.